Company News
-
AACC2022 | GENESIS Attends the Exhibition with THREE principal themes
AACC2022 | GENESIS Attends the Exhibition with THREE principal themes Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. has participated in the Annual Scientific Meeting & Clinical Expo in Chicago, USA, between Jul.26th-28th, 2022 with THREE principal themes including Infectious Diseas...Read more -
Breaking news! GENESIS Flu & COVID-19 Antigen Duo Test Gets CE Self-Test Certification
Breaking news! GENESIS Flu & COVID-19 Antigen Duo Test Gets CE Self-Test Certification On May 25, Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. independently developed a multiple antigen test kit for home self-testing of SARS-CoV-2, influenza A (Flu A) and influenza B (Flu B)—EZERT...Read more -
Tuberculosis, An Old and Highly Infectious Disease That Still Needs Attention in COVID-19 Pandemic
Tuberculosis, An Old and Highly Infectious Disease That Still Needs Attention in COVID-19 Pandemic Recently, several SARS-CoV-2 variants outbreaks in multiple regions again. During the COVID-19 pandemic, the tuberculosis disease (TB) which has the similar symptom to COVID-19 that also invades pul...Read more -
Genesis Sampling Swabs Virus Sample Collection Kit in One-stop Service
Genesis Sampling Swabs Virus Sample Collection Kit in One-stop Service As the first step of detection, the sampling quality directly affects the results of a series of subsequent detections, and this step is usually lack of enough attention or even ignored. To ensure the quality of samplin...Read more -
Dengue Fever – Caused by a Mosquito
Dengue Fever – Caused by a Mosquito Timor-Leste has reported a surge of dengue cases since late 2021, at unusually high levels compared to previous years. There were 1451 reported cases and 10 deaths (CFR 0.7%) in 2020 and 901 cases and 11 deaths (CFR 1.2%) in 2021. In January 2022 a...Read more -
HHS Classified H. pylori as a Definite Carcinogen
HHS Classified H. pylori as a Definite Carcinogen The U.S. Department of Health and Human Services (HHS) released the 15th Report on Carcinogens on December 21, 2021. The Report on Carcinogens is a congressionally mandated, science-based public health document that NTP prepares for the HHS...Read more -
New Arrival | KaiBiLi COVID-19 Neutralization Ab+ Rapid Test Helps to Immunity Detection
New Arrival | KaiBiLi COVID-19 Neutralization Ab+ Rapid Test Helps to Immunity Detection Globally, the number of COVID-19 new cases increased markedly in the past week (3-9 January 2022), while the number of new deaths remained similar to that of the previous week. Across the six regions, ...Read more -
GENESIS products continue to detect SARS-CoV-2 mutant strain Omicron
On 26 November WHO designated B.1.1.529 a variant of concern(VOC) because of preliminary evidence of a detrimental change in COVID-19 epidemiology. As a VOC, it was named Omicron. Omicron has a large number of mutations including more than 30 genetic mutations of the spike protein. Some mutations...Read more -
Genesis COVID-19 IVD TOTAL SOLUTION
Genesis COVID-19 IVD TOTAL SOLUTION Globally, as of 4:08pm CET, 9 December 2021, there have been 267,184,623 confirmed cases of COVID-19, including 5,277,327 deaths, reported to WHO. As of 8 December 2021, a total of 8,158,815,265 vaccine doses have been administered. We Genesis launch our...Read more -
MEDICA | GENESIS Attends the Exhibition with Flu&COVID-19 Solutions
MEDICA | GENESIS Attends the Exhibition with Flu&COVID-19 Solutions Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. participated in the 53rd MEDICA 2021 World Forum for Medicine in DÜSSELDORF, GERMANY between Nov. 15th-18th. About MEDICA： “MEDICA” was been Founded in 1968, a...Read more -
Meet Genesis in MEDICA,Düsseldorf Germany!
●Time: Nov 15-18th, 2021 ●Booth No: 3H14-2 If you would like to get more information about our COVID-19 Total Solution and other reagents, warmly welcome to visit our booth at MEDICA. Genesis is looking forward to meeting you here! If you need support or more information please contact us: Tel...Read more -
KaibiLi COVID-19 Antigen on PEI (Paul-Ehrlich-Institut ) Approval List!
KaibiLi COVID-19 Antigen get PEI approval KaibiLi COVID-19 Antigen get PEI approval. The BfArM provides a list according to § 1 sentence 1 TestV of the antigen tests for the direct detection of pathogens of the coronavirus SARS-CoV-2, which are intended by the manufacturer for professional use (&...Read more
